JP2006515560A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006515560A5 JP2006515560A5 JP2004512682A JP2004512682A JP2006515560A5 JP 2006515560 A5 JP2006515560 A5 JP 2006515560A5 JP 2004512682 A JP2004512682 A JP 2004512682A JP 2004512682 A JP2004512682 A JP 2004512682A JP 2006515560 A5 JP2006515560 A5 JP 2006515560A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- substituted
- unbranched
- branched
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38946102P | 2002-06-17 | 2002-06-17 | |
| US10/463,009 US7037936B2 (en) | 2002-06-17 | 2003-06-16 | Compounds useful for the treatment of cancer, compositions thereof and methods therewith |
| PCT/US2003/018905 WO2003105774A2 (en) | 2002-06-17 | 2003-06-17 | Compounds useful for the treatment of cancer, compositions thereof and methods therewith |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006515560A JP2006515560A (ja) | 2006-06-01 |
| JP2006515560A5 true JP2006515560A5 (https=) | 2006-08-03 |
Family
ID=29740147
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004512682A Pending JP2006515560A (ja) | 2002-06-17 | 2003-06-17 | 癌の治療に有用な化合物、その組成物、およびそれを用いる方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7037936B2 (https=) |
| EP (1) | EP1551388A4 (https=) |
| JP (1) | JP2006515560A (https=) |
| CN (1) | CN1674888A (https=) |
| AU (1) | AU2003243587B2 (https=) |
| CA (1) | CA2488891A1 (https=) |
| IL (1) | IL165839A0 (https=) |
| MX (1) | MXPA04012675A (https=) |
| NZ (1) | NZ537653A (https=) |
| WO (1) | WO2003105774A2 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050100529A1 (en) * | 2003-11-06 | 2005-05-12 | Zeldis Jerome B. | Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of asbestos-related diseases and disorders |
| US8175808B2 (en) * | 2005-04-01 | 2012-05-08 | Sloan Kettering Institute For Cancer Research | Method for determining disease treatment duration |
| EP1957507B1 (en) | 2005-12-02 | 2018-10-24 | Ionis Pharmaceuticals, Inc. | Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents |
| WO2010030690A1 (en) | 2008-09-10 | 2010-03-18 | Isis Pharmaceuticals, Inc. | Antibacterial 4,6-substituted 6', 6" and 1 modified aminoglycoside analogs |
| WO2010030704A2 (en) | 2008-09-10 | 2010-03-18 | Achaogen, Inc. | Antibacterial aminoglycoside analogs |
| WO2010042850A1 (en) | 2008-10-09 | 2010-04-15 | Achaogen, Inc. | Antibacterial aminoglycoside analogs |
| WO2010042851A1 (en) | 2008-10-09 | 2010-04-15 | Achaogen, Inc. | Antibacterial aminoglycoside analogs |
| EP2486044A2 (en) | 2009-10-09 | 2012-08-15 | Achaogen, Inc. | Antibacterial aminoglycoside analogs |
| US9200008B2 (en) | 2010-07-02 | 2015-12-01 | Aska Pharmaceutical Co., Ltd. | Heterocyclic compound and p27Kip1 degradation inhibitor |
| CN103282370A (zh) | 2010-11-17 | 2013-09-04 | 尔察祯有限公司 | 抗菌氨基糖苷类类似物 |
| WO2012075232A1 (en) * | 2010-12-04 | 2012-06-07 | Trevena, Inc. | Opioid receptor ligands and methods of using and making the same |
| JP2024523237A (ja) | 2021-06-18 | 2024-06-28 | ホンジーン バイオテック コーポレイション | 官能化されたｎ－アセチルガラクトサミンヌクレオシド |
| JP2024532271A (ja) | 2021-08-30 | 2024-09-05 | ホンジーン バイオテック コーポレイション | 官能化ｎ－アセチルガラクトサミンアナログ |
| WO2023114746A1 (en) | 2021-12-15 | 2023-06-22 | Hongene Biotech Corporation | Functionalized n-acetylgalactosamine analogs |
| WO2024118503A1 (en) | 2022-11-28 | 2024-06-06 | Hongene Biotech Corporation | Functionalized n-acetylgalactosamine analogs |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3328249A (en) * | 1965-06-21 | 1967-06-27 | Sterling Drug Inc | Process for counteracting depressive states |
| US3485873A (en) * | 1966-12-21 | 1969-12-23 | Sterling Drug Inc | N-benzyl-n-methyl-omega-phenyl-omega-cycloalkyl-lower-alkylamines |
| GB9201755D0 (en) | 1992-01-28 | 1992-03-11 | British Bio Technology | Compounds |
| AU767507B2 (en) | 1998-08-28 | 2003-11-13 | New York University | Novel ubiquitin ligases as therapeutic targets |
| ES2361660T3 (es) | 1998-12-10 | 2011-06-21 | Signal Pharmaceuticals Llc | Ubicutina-ligasa e3 humana para la modulación de nk-kappa b. |
| US20010044445A1 (en) * | 1999-04-08 | 2001-11-22 | Bamaung Nwe Y. | Azole inhibitors of cytokine production |
| NZ527047A (en) | 2001-01-05 | 2006-09-29 | Univ New York | Methods to identify compounds useful for the treatment of proliferative and differentiative disorders |
| WO2003101983A1 (en) * | 2002-05-31 | 2003-12-11 | Yamanouchi Pharmaceutical Co., Ltd. | Tetrahydropyran derivative |
-
2003
- 2003-06-16 US US10/463,009 patent/US7037936B2/en not_active Expired - Fee Related
- 2003-06-17 NZ NZ537653A patent/NZ537653A/en unknown
- 2003-06-17 CA CA002488891A patent/CA2488891A1/en not_active Abandoned
- 2003-06-17 AU AU2003243587A patent/AU2003243587B2/en not_active Ceased
- 2003-06-17 MX MXPA04012675A patent/MXPA04012675A/es active IP Right Grant
- 2003-06-17 CN CNA038193191A patent/CN1674888A/zh active Pending
- 2003-06-17 IL IL16583903A patent/IL165839A0/xx unknown
- 2003-06-17 EP EP03760389A patent/EP1551388A4/en not_active Withdrawn
- 2003-06-17 WO PCT/US2003/018905 patent/WO2003105774A2/en not_active Ceased
- 2003-06-17 JP JP2004512682A patent/JP2006515560A/ja active Pending
-
2006
- 2006-02-17 US US11/357,774 patent/US20060142352A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006515560A5 (https=) | ||
| US9895373B2 (en) | Substituted pyrazolo[3,4-D]pyrimidines and uses thereof | |
| ES2510674T3 (es) | Inhibidores de la proteína humana tirosina fosfatasa y su uso farmacéutico | |
| JP2824917B2 (ja) | 抗腫瘍剤 | |
| WO2008123755A1 (en) | A pharmaceutical compositions containing lactam type pyridine derivatives as an effective ingredient for the prevention and treatment of ischemia | |
| JP2021534158A5 (https=) | ||
| Van Es et al. | The VX2 carcinoma in the rabbit auricle as an experimental model for intra-arterial embolization of head and neck squamous cell carcinoma with dextran microspheres | |
| JPWO2020037091A5 (https=) | ||
| Al Hussein et al. | Challenges in perioperative animal care for orthotopic implantation of tissue-engineered pulmonary valves in the ovine model | |
| TWI862414B (zh) | 難治性癌症之預防或治療用之醫藥組合物 | |
| PT1105136E (pt) | Método para tratar doenças oculares neovasculares | |
| EP0794786B1 (en) | The use of inositoltrisphosphate for the preparing of medicaments | |
| US20110269784A1 (en) | Use of tetrahydropyrimidines | |
| Duff et al. | High-dose nitrogen mustard therapy with intermittent aortic occlusion | |
| Sutanto-Ward et al. | Adjuvant chemotherapy for colorectal hepatic metastases: role of route of administration and timing | |
| RU2010118458A (ru) | Производное изоксазола для лечения рака | |
| CN210331361U (zh) | 多孔缓释化疗植入体 | |
| RU2599043C1 (ru) | Способ комбинированного лечения местнораспространенного рака прямой кишки | |
| CN109806263A (zh) | 一种药物组合物及其制备方法和用途 | |
| ES2965179T3 (es) | Derivado polimérico soluble en agua de venetoclax | |
| CN103127510B (zh) | 含有肝细胞生长因子受体抑制剂和Bcl-2抑制剂的药物组合物及其应用 | |
| CN107625781B (zh) | miRNA抑制子在制备防治心肌梗死药物中的应用 | |
| ES2932270B2 (es) | Compuesto de rutenio (iii) y 2,2'-biimidazol (runat-bi) y su uso terapeutico | |
| JP4522261B2 (ja) | ブドウ膜黒色腫の処置 | |
| WO2025209574A1 (zh) | 用于预防或治疗肿瘤的parp7抑制剂 |